Moderna, Inc. (MRNA)

Basic

  • Market Cap

    $29.63B

  • EV

    $18.23B

  • Shares Out

    381.28M

  • Revenue

    $9,121M

  • Employees

    3,900

Margins

  • Gross

    -13.28%

  • EBITDA

    -23.75%

  • Operating

    -29.22%

  • Pre-Tax

    -25.84%

  • Net

    -38%

  • FCF

    -29.13%

Returns (5Yr Avg)

  • ROA

    5.67%

  • ROE

    16.53%

  • ROCE

    19.01%

  • ROIC

    -9.87%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $139.9

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $23.78

  • Earnings (Dil)

    -$9.04

  • FCF

    -$6.93

  • Book Value

    $35.31

Growth (CAGR)

  • Rev 3Yr

    233.43%

  • Rev 5Yr

    116.55%

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    76.86%

  • Dil EPS 5Yr

    14.69%

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    -51.46%

  • EBITDA Fwd 2Yr

    -67.53%

  • EPS Fwd 2Yr

    -72.29%

  • EPS LT Growth Est

    -162%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM
Metric
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Revenues

135.1

60.0

803.0

18,471.0

19,263.0

9,565.0

Other Revenues, Total

—

—

—

—

—

-444.0

Total Revenues

135.1

60.0

803.0

18,471.0

19,263.0

9,121.0

Total Revenues % Chg.

-34.4%

-55.6%

1,238.3%

2,200.2%

4.3%

-57.4%

Cost of Goods Sold, Total

454.1

496.0

1,378.0

4,608.0

8,711.0

10,332.0

Gross Profit

-319.0

-436.0

-575.0

13,863.0

10,552.0

-1,211.0

Selling General & Admin Expenses, Total

94.3

110.0

188.0

567.0

1,132.0

1,454.0

Other Operating Expenses, Total

94.3

110.0

188.0

567.0

1,132.0

1,454.0

Operating Income

-413.3

-546.0

-763.0

13,296.0

9,420.0

-2,665.0

Interest Expense, Total

-3.1

—

-10.0

-17.0

-29.0

-42.0

Interest And Investment Income

27.0

39.0

25.0

18.0

200.0

405.0

Net Interest Expenses

23.9

39.0

15.0

1.0

171.0

363.0

Currency Exchange Gains (Loss)

—

—

—

-8.0

48.0

3.0

Other Non Operating Income (Expenses)

-1.2

-8.0

4.0

-5.0

-44.0

-6.0

EBT, Excl. Unusual Items

-390.5

-515.0

-744.0

13,284.0

9,595.0

-2,305.0

Gain (Loss) On Sale Of Investments

0.0

—

—

1.0

-20.0

-52.0

Gain (Loss) On Sale Of Assets

-0.9

—

—

—

—

—

Other Unusual Items

7.0

—

—

—

—

—

EBT, Incl. Unusual Items

-384.4

-515.0

-744.0

13,285.0

9,575.0

-2,357.0

Income Tax Expense

0.3

-1.0

3.0

1,083.0

1,213.0

1,109.0

Earnings From Continuing Operations

-384.7

-514.0

-747.0

12,202.0

8,362.0

-3,466.0

Net Income

-384.7

-514.0

-747.0

12,202.0

8,362.0

-3,466.0

Preferred Dividend and Other Adjustments

17.1

—

—

—

—

—

Net Income to Common Incl Extra Items

-401.9

-514.0

-747.0

12,202.0

8,362.0

-3,466.0

Net Income to Common Excl. Extra Items

-401.9

-514.0

-747.0

12,202.0

8,362.0

-3,466.0

Total Shares Outstanding

328.8

336.5

398.8

403.0

385.0

381.0

Weighted Avg. Shares Outstanding

81.1

331.0

381.0

403.0

394.0

383.5

Weighted Avg. Shares Outstanding Dil

81.1

331.0

381.0

431.0

416.0

383.5

EPS

-5.0

-1.6

-2.0

30.3

21.2

-9.0

EPS Diluted

-5.0

-1.6

-2.0

28.3

20.1

-9.0

EBITDA

-388.4

-515.0

-732.0

13,528.0

9,768.0

-2,166.0